# NALOXONE HYDROCHLORIDE

NDC: 0404-9923
Generic name: naloxone hydrochloride
Labeler / Manufacturer: Henry Schein, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20220113
Marketing ended: 20260731
FDA application: ANDA207633

## Active ingredients

- NALOXONE HYDROCHLORIDE: .4 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0404-9923"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0404-9923
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10c22ce2-7dbe-4417-b8b4-602b190b1ddd